| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Cardiovascular Research and Lipid Lipoprotein Research Groups, Departments of Pediatrics and Pharmacology, Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2S2; and 2 Ohio State Biotechnology Center and Department of Biochemistry, Ohio State University, Columbus, Ohio 43210
Malonyl-CoA is a potent inhibitor of fatty acid uptake into the mitochondria. Although the synthesis of malonyl-CoA in the heart by acetyl-CoA carboxylase (ACC) has been well characterized, no information is available as to how malonyl-CoA is degraded. We demonstrate that malonyl-CoA decarboxylase (MCD) activity is present in the heart. Partial purification revealed a protein of ~50 kDa. The role of MCD in regulating fatty acid oxidation was also studied using isolated, perfused hearts from newborn rabbits and adult rats. Fatty acid oxidation in rabbit hearts increased dramatically between 1 day and 7 days after birth, which was accompanied by a decrease in both ACC activity and malonyl-CoA levels and a parallel increase in MCD activity. When adult rat hearts were aerobically reperfused after a 30-min period of no-flow ischemia, levels of malonyl-CoA decreased dramatically, which was accompanied by a decrease in ACC activity, a maintained MCD activity, and an increase in fatty acid oxidation rates. Taken together, our data suggest that the heart has an active MCD that has an important role in regulating fatty acid oxidation rates.
acetyl-coenzyme A carboxylase; carnitine O-palmitoyltransferase I
This article has been cited by other articles:
|
|
 |
|
  G. R. Steinberg and B. E. Kemp AMPK in Health and Disease Physiol Rev, July 1, 2009; 89(3): 1025 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Dzamko, J. D. Schertzer, J. G. Ryall, R. Steel, S. L. Macaulay, S. Wee, Z.-P. Chen, B. J. Michell, J. S. Oakhill, M. J. Watt, et al. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation J. Physiol., December 1, 2008; 586(23): 5819 - 5831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Saeedi, H. L. Parsons, R. B. Wambolt, K. Paulson, V. Sharma, J. R. B. Dyck, R. W. Brownsey, and M. F. Allard Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2497 - H2506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Sharma, P. Dhillon, R. Wambolt, H. Parsons, R. Brownsey, M. F. Allard, and J. H. McNeill Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1609 - H1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Qi, D. An, G. Kewalramani, Y. Qi, T. Pulinilkunnil, A. Abrahani, U. Al-Atar, S. Ghosh, R. B. Wambolt, M. F. Allard, et al. Altered cardiac fatty acid composition and utilization following dexamethasone-induced insulin resistance Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E420 - E427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Stanley, E. E. Morgan, H. Huang, T. A. McElfresh, J. P. Sterk, I. C. Okere, M. P. Chandler, J. Cheng, J. R. B. Dyck, and G. D. Lopaschuk Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2304 - H2309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. King, I. C. Okere, N. Sharma, J. R. B. Dyck, A. E. Reszko, T. A. McElfresh, J. Kerner, M. P. Chandler, G. D. Lopaschuk, and W. C. Stanley Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1033 - H1037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bartelds, J. Takens, G. B. Smid, V. A. Zammit, C. Prip-Buus, J. R. G. Kuipers, and F. R. van der Leij Myocardial carnitine palmitoyltransferase I expression and long-chain fatty acid oxidation in fetal and newborn lambs Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2243 - H2248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. O. Besikci, F. M. Campbell, T. A. Hopkins, J. R. B. Dyck, and G. D. Lopaschuk Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H283 - H289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Poirier, G. Vincent, A. E. Reszko, B. Bouchard, J. K. Kelleher, H. Brunengraber, and C. Des Rosiers Probing the link between citrate and malonyl-CoA in perfused rat hearts Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1379 - H1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. M. Soltys, L. Buchholz, M. Gandhi, A. S. Clanachan, K. Walsh, and J. R. B. Dyck Phosphorylation of cardiac protein kinase B is regulated by palmitate Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1056 - H1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Recchia, J. C. Osorio, M. P. Chandler, X. Xu, A. R. Panchal, G. D. Lopaschuk, T. H. Hintze, and W. C. Stanley Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E197 - E206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Longnus, R. B. Wambolt, R. L. Barr, G. D. Lopaschuk, and M. F. Allard Regulation of myocardial fatty acid oxidation by substrate supply Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1561 - H1567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chien, D. Dean, A. K. Saha, J. P. Flatt, and N. B. Ruderman Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E259 - E265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sakamoto, R. L. Barr, K. M. Kavanagh, and G. D. Lopaschuk Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1196 - H1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Kantor, A. Lucien, R. Kozak, and G. D. Lopaschuk The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase Circ. Res., March 17, 2000; 86(5): 580 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Goodwin and H. Taegtmeyer Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E772 - E777. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
